Cargando…
Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578254/ https://www.ncbi.nlm.nih.gov/pubmed/36253862 http://dx.doi.org/10.1186/s13054-022-04181-z |
_version_ | 1784811933245898752 |
---|---|
author | Winiszewski, Hadrien Piton, Gael Capellier, Gilles |
author_facet | Winiszewski, Hadrien Piton, Gael Capellier, Gilles |
author_sort | Winiszewski, Hadrien |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9578254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95782542022-10-19 Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors Winiszewski, Hadrien Piton, Gael Capellier, Gilles Crit Care Correspondence BioMed Central 2022-10-17 /pmc/articles/PMC9578254/ /pubmed/36253862 http://dx.doi.org/10.1186/s13054-022-04181-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correspondence Winiszewski, Hadrien Piton, Gael Capellier, Gilles Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors |
title | Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors |
title_full | Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors |
title_fullStr | Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors |
title_full_unstemmed | Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors |
title_short | Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors |
title_sort | early hyperoxia and 28-day mortality in patients on venoarterial ecmo support for refractory cardiogenic shock: discussion about potential confounding factors |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578254/ https://www.ncbi.nlm.nih.gov/pubmed/36253862 http://dx.doi.org/10.1186/s13054-022-04181-z |
work_keys_str_mv | AT winiszewskihadrien earlyhyperoxiaand28daymortalityinpatientsonvenoarterialecmosupportforrefractorycardiogenicshockdiscussionaboutpotentialconfoundingfactors AT pitongael earlyhyperoxiaand28daymortalityinpatientsonvenoarterialecmosupportforrefractorycardiogenicshockdiscussionaboutpotentialconfoundingfactors AT capelliergilles earlyhyperoxiaand28daymortalityinpatientsonvenoarterialecmosupportforrefractorycardiogenicshockdiscussionaboutpotentialconfoundingfactors |